Estimation of growth fraction with bromodeoxyuridine in human central nervous system tumors
β Scribed by Yoshii, Yoshihiko; Maki, Yutaka; Tsuboi, Koji; Tomono, Yuji; Nakagawa, Kunio; Hoshino, Takao
- Book ID
- 127180653
- Publisher
- American Association of Neurological Surgeons
- Year
- 1986
- Tongue
- English
- Weight
- 571 KB
- Volume
- 65
- Category
- Article
- ISSN
- 1933-0693
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Methotrexate osteopathy, previously reported as a complication of maintenanceβtherapy for acute lymphoblastic leukemia, is characterized by osteopenia, particularly involving the lower extremities, thick, dense provisional zones of calcification, growth arrest lines, and corner fracture
## Abstract ## BACKGROUND The current study was performed to determine the maximum tolerated dose (MTD), toxicity, and outcome of infusional 5 bromoβ2'βdeoxyuridine (bromodeoxyuridine; BUdR) given with accelerated fractionation whole brain radiation therapy (WBRT) after chemotherapy for the treatm